Home
Conditions
Lymphoma

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

3,646 public trials 848 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma trial results

Completed

Prognosis Of Patients With Aggressive B-Cell Lymphoma, Treated With Rituximab+Anthracycline Regimen

NCT01478269

Conditions: B-Cell Lymphomas, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Hemocentro-Unicamp Campinas, Brazil

Centro Medico Santa Isabel, Brazil

Centro Paulista de Oncologia São Paulo, Brazil

Santa Casa Medical School São Paulo, Brazil

View all 39 locations

View Trial Details

Completed

HDCT and Stem Cell Transplantation for Mantle Cell and Relapsed Low Grade Non-hodgkin's Lymphoma

NCT00144092

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Tom Baker Cancer Centre Calgary, Alberta, Canada

View Trial Details

Completed

Prevention of Methotrexate Induced Nephrotoxicity and Prolonged Drug Elimination Time With 12 Hours Prehydration

NCT00570817

Conditions: Ependymoma, Glioma, Hematologic Diseases, +20 more
Locations: Aarhus University Hospital, Skejby Aarhus, Aarhus N, Denmark

View Trial Details

Completed

A Study to Compare Oxycodone/Naloxone Prolonged Release Against Codeine/Paracetamol in the Treatment of Moderate to Severe Chronic Low Back Pain or Pain Due to Osteoarthritis

NCT00784810

Conditions: Arthritis, Back Pain, Hemic and Lymphatic Diseases, +17 more
Locations: Coventry, United Kingdom

View Trial Details

Completed

Oxaliplatin, Fludarabine, Cytarabine and Rituximab in Richter's Syndrome, Refractory CLL and PLL

NCT00452374

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +16 more
Locations: University of California-San Diego La Jolla, California, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Study Of Yttrium-ibritumomab (Zevalin) For the Treatment Of Patients With Relapsed And Refractory Mantle Cell Lymphoma

NCT00038623

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Study of Recombinant Human-Mouse Chimeric Anti-CD20 Monoclonal Antibody to Treat Non-hodgkin's Lymphoma

NCT01459887

Conditions: Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: SUN-YAT-SEN university cancer center Guangzhou, Guangdong, China

View Trial Details

Completed

A Safety/Efficacy Study of SGN-30 (Antibody) in Patients With Refractory or Recurrent CD30+ Hematologic Malignancies

NCT00051597

Conditions: DNA Virus Infections, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +22 more
Locations: University of Alabama, Birmingham Birmingham, Alabama, United States

USC Norris Cancer Center Los Angeles, California, United States

University of Miami Miami, Florida, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

The Effectiveness of Alemtuzumab Given in Combination With CHOP and ESHAP in Patients Newly Diagnosed With Peripheral T-Cell Lymphoma (PTCL)

NCT00930605

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: King Chulalongkorn Memorial Hospital Bangkok, Thailand

View Trial Details

Completed

Study of the Safety and Tolerability of Oral Capsule Form of PCI-24781 in Advanced Cancer Patients

NCT00562224

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +26 more
Locations: California Cancer Care Greenbrae, California, United States

University of Chicago Chicago, Illinois, United States

Sarah Cannon Research Institue Nashville, Tennessee, United States

MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Lymphoma

Lymphoma trial results

Related conditions